{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:31:30Z","timestamp":1790685090227,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Molecular Medicine Ireland"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.canlet.2016.01.012","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T15:46:22Z","timestamp":1453131982000},"page":"147-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["Lung cancer stem cells: The root of resistance"],"prefix":"10.1016","volume":"372","author":[{"given":"Lauren","family":"MacDonagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamon","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Cuffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"O'Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2016.01.012_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.canlet.2016.01.012_bib0015","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0020","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer","volume":"359","author":"Herbst","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2016.01.012_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drup.2010.02.001","article-title":"Implication of microRNAs in drug resistance for designing novel cancer therapy","volume":"13","author":"Sarkar","year":"2010","journal-title":"Drug Resist. Updat"},{"key":"10.1016\/j.canlet.2016.01.012_bib0030","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/1535-7163.MCT-10-0397","article-title":"Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics","volume":"9","author":"Allen","year":"2010","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.canlet.2016.01.012_bib0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.canlet.2016.01.012_bib0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells: an evolving concept","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.01.012_bib0050","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/nature04956","article-title":"Asymmetric and symmetric stem-cell divisions in development and cancer","volume":"441","author":"Morrison","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.01.012_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10616-008-9173-9","article-title":"A rat mammary gland cancer cell with stem cell properties of self-renewal and multi-lineage differentiation","volume":"58","author":"Cocola","year":"2008","journal-title":"Cytotechnology"},{"key":"10.1016\/j.canlet.2016.01.012_bib0060","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"Diehn","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.01.012_bib0065","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/cdd.2010.150","article-title":"Acidic stress promotes a glioma stem cell phenotype","volume":"18","author":"Hjelmeland","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.canlet.2016.01.012_bib0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/wdev.56","article-title":"Stress and stem cells","volume":"1","author":"Tower","year":"2012","journal-title":"Wiley Interdiscip. Rev. Dev. Biol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1476-4598-10-96","article-title":"Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer","volume":"10","author":"Serrano","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0080","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.18632\/oncotarget.1246","article-title":"Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells","volume":"4","author":"Liu","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2016.01.012_bib0085","first-page":"003","article-title":"Chemotherapy-induced enrichment of cancer stem cells in lung cancer","volume":"S9","author":"Hamilton","year":"2013","journal-title":"J. Bioanal. Biomed"},{"key":"10.1016\/j.canlet.2016.01.012_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2016.01.012_bib0095","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.4161\/cbt.22007","article-title":"Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate","volume":"13","author":"Wintzell","year":"2012","journal-title":"Cancer Biol. Ther"},{"key":"10.1016\/j.canlet.2016.01.012_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003077","article-title":"Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties","volume":"3","author":"Levina","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0105","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/jnci\/djq361","article-title":"Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics","volume":"102","author":"Calcagno","year":"2010","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2016.01.012_bib0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/0008-5472.CAN-12-1733","article-title":"Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling","volume":"73","author":"Liu","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s13277-013-0675-5","article-title":"Fluorouracil selectively enriches stem-like cells in the lung adenocarcinoma cell line SPC","volume":"34","author":"Shi","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ejca.2010.02.039","article-title":"Cancer metastasis as a therapeutic target","volume":"46","author":"Sleeman","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0125","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/nar\/gkl303","article-title":"Telomeres, chromosome instability and cancer","volume":"34","author":"Bailey","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2008.09.034","article-title":"Telomerase reverse transcriptase delays aging in cancer-resistant mice","volume":"135","author":"Tomas-Loba","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2016.01.012_bib0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1101\/sqb.2005.70.030","article-title":"Telomerase and cancer stem cells","volume":"70","author":"Armanios","year":"2005","journal-title":"Cold Spring Harb. Symp. Quant. Biol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0140","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/mol.105.011494","article-title":"Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment","volume":"68","author":"Ward","year":"2005","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0145","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1158\/1535-7163.MCT-06-0033","article-title":"Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells","volume":"5","author":"Cerone","year":"2006","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.canlet.2016.01.012_bib0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.stem.2014.11.010","article-title":"Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy","volume":"15","author":"Bruedigam","year":"2014","journal-title":"Cell Stem. Cell"},{"key":"10.1016\/j.canlet.2016.01.012_bib0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10549-015-3270-1","article-title":"The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2(+) breast cancer cells","volume":"149","author":"Koziel","year":"2015","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.canlet.2016.01.012_bib0160","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.canlet.2011.01.013","article-title":"Targeting apoptosis pathways in cancer stem cells","volume":"332","author":"Signore","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2016.01.012_bib0165","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/aps.2013.27","article-title":"Understanding and targeting cancer stem cells: therapeutic implications and challenges","volume":"34","author":"Chen","year":"2013","journal-title":"Acta Pharmacol. Sin"},{"key":"10.1016\/j.canlet.2016.01.012_bib0170","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","article-title":"Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells","volume":"67","author":"Ho","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12094-011-0656-3","article-title":"A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer","volume":"13","author":"Perona","year":"2011","journal-title":"Clin. Transl. Oncol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0185","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.18632\/oncotarget.3076","article-title":"Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2016.01.012_bib0190","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.01.012_bib0195","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1158\/0008-5472.CAN-13-2702","article-title":"Activin upregulation by NF-kappaB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer","volume":"75","author":"Wamsley","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0200","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature06835","article-title":"Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling","volume":"452","author":"Malanchi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.01.012_bib0205","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1517\/14712598.2010.504705","article-title":"Microenvironmental targeting of Wnt\/beta-catenin signals for hematopoietic stem cell regulation","volume":"10","author":"Oh","year":"2010","journal-title":"Expert Opin. Biol. Ther"},{"key":"10.1016\/j.canlet.2016.01.012_bib0210","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2013.12.004","article-title":"Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT\/beta-catenin\/Snail signaling pathway","volume":"723","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2010.01.028","article-title":"Wnt\/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells","volume":"392","author":"Teng","year":"2010","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2016.01.012_bib0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni1164","article-title":"Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance","volume":"6","author":"Duncan","year":"2005","journal-title":"Nat. Immunol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0225","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1158\/1078-0432.CCR-12-0370","article-title":"Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma","volume":"19","author":"Hassan","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0230","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1158\/1078-0432.CCR-14-0507","article-title":"Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells","volume":"21","author":"Justilien","year":"2015","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0235","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/bjc.2014.625","article-title":"Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer","volume":"112","author":"Zuo","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1756-8722-6-77","article-title":"Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs","volume":"6","author":"Ahmad","year":"2013","journal-title":"J. Hematol. Oncol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068597","article-title":"NF-kappaB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0250","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1182\/blood.V75.10.1947.1947","article-title":"Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells","volume":"75","author":"Kastan","year":"1990","journal-title":"Blood"},{"issue":"Pt 2","key":"10.1016\/j.canlet.2016.01.012_bib0255","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/bj3390387","article-title":"Molecular analysis of two closely related mouse aldehyde dehydrogenase genes: identification of a role for Aldh1, but not Aldh-pb, in the biosynthesis of retinoic acid","volume":"339","author":"Hsu","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2016.01.012_bib0260","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem. Cell"},{"key":"10.1016\/j.canlet.2016.01.012_bib0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-61779-980-8_27","article-title":"ALDH as a marker for enriching tumorigenic human colonic stem cells","volume":"916","author":"Shenoy","year":"2012","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0270","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hed.21315","article-title":"Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase","volume":"32","author":"Clay","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2016.01.012_bib0275","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1158\/0008-5472.CAN-09-3806","article-title":"High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer","volume":"70","author":"van den Hoogen","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0280","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/labinvest.2009.127","article-title":"ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome","volume":"90","author":"Li","year":"2010","journal-title":"Lab. Invest"},{"key":"10.1016\/j.canlet.2016.01.012_bib0285","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/1541-7786.MCR-08-0393","article-title":"Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer","volume":"7","author":"Jiang","year":"2009","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0290","first-page":"1","article-title":"Downregulation of ALDH1A1 expression in non-small cell lung carcinomas\u2013its clinicopathologic and biological significance","volume":"6","author":"Okudela","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1078-0432.CCR-09-1630","article-title":"Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer","volume":"16","author":"Charafe-Jauffret","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0300","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-10-0881","article-title":"Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling","volume":"70","author":"Sullivan","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12013-014-9844-4","article-title":"Lung cancer stem cells and implications for future therapeutics","volume":"69","author":"Wang","year":"2014","journal-title":"Cell Biochem. Biophys"},{"key":"10.1016\/j.canlet.2016.01.012_bib0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054193","article-title":"Generation and characterisation of Cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature","volume":"8","author":"Barr","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079798","article-title":"Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis","volume":"8","author":"Larzabal","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0320","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2011.06.003","article-title":"Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro","volume":"99","author":"Mihatsch","year":"2011","journal-title":"Radiother. Oncol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0325","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1158\/0008-5472.CAN-12-4136","article-title":"Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells","volume":"73","author":"Shien","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0330","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-13-3724","article-title":"EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling","volume":"74","author":"Arasada","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0335","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2012.08.021","article-title":"ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors","volume":"328","author":"Huang","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2016.01.012_bib0340","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.4161\/cc.26417","article-title":"Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin","volume":"12","author":"Corominas-Faja","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2016.01.012_bib0345","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/1471-2407-14-304","article-title":"Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity","volume":"14","author":"Cortes-Dericks","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0350","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-7-87","article-title":"ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells","volume":"7","author":"Moreb","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0355","first-page":"2679","article-title":"Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3","volume":"32","author":"O'Brien","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0360","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.18632\/oncotarget.1992","article-title":"Blocking the formation of radiation-induced breast cancer stem cells","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2016.01.012_bib0365","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.molonc.2015.02.007","article-title":"Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer","volume":"9","author":"Allensworth","year":"2015","journal-title":"Mol. Oncol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0370","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","article-title":"A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer","volume":"20","author":"Nechushtan","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2016.01.012_bib0375","article-title":"The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells","volume":"7","author":"Shi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1476-4598-11-73","article-title":"EGFR\/Src\/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer","volume":"11","author":"Singh","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0385","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/bjc.2011.94","article-title":"Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer","volume":"104","author":"Xiang","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0390","article-title":"betaArrestin-1 and Mcl-1 modulate self-renewal growth of cancer stem-like side-population cells in non-small cell lung cancer","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0395","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10238-011-0135-8","article-title":"Effects of the Hedgehog pathway inhibitor GDC-0449 on lung cancer cell lines are mediated by side populations","volume":"12","author":"Tian","year":"2012","journal-title":"Clin. Exp. Med"},{"key":"10.1016\/j.canlet.2016.01.012_bib0400","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1158\/0008-5472.CAN-11-3983","article-title":"Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells","volume":"72","author":"Zhang","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0405","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bbrc.2015.01.035","article-title":"Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma","volume":"457","author":"Wu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2016.01.012_bib0410","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bcp.2013.04.003","article-title":"Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2","volume":"85","author":"Hu","year":"2013","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041035","article-title":"Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation","volume":"7","author":"Niu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0420","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2119\/molmed.2011.00444","article-title":"Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2","volume":"18","author":"Wang","year":"2012","journal-title":"Mol. Med"},{"key":"10.1016\/j.canlet.2016.01.012_bib0425","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/0008-5472.CAN-09-1102","article-title":"Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop","volume":"70","author":"Levina","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0430","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1182\/blood.V93.4.1435","article-title":"Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells","volume":"93","author":"Horn","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2016.01.012_bib0435","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMra043666","article-title":"Neural stem cells and the origin of gliomas","volume":"353","author":"Sanai","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2016.01.012_bib0440","first-page":"345","article-title":"Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance","volume":"19","author":"Pircher","year":"2008","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.01.012_bib0445","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/bcr1855","article-title":"Brca1 breast tumors contain distinct CD44+\/CD24- and CD133+ cells with cancer stem cell characteristics","volume":"10","author":"Wright","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0450","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O'Brien","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.01.012_bib0455","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-06-4429","article-title":"Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens","volume":"67","author":"Miki","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0460","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ijc.22476","article-title":"CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity","volume":"120","author":"Yin","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0465","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","article-title":"CD133 expression defines a tumor initiating cell population in primary human ovarian cancer","volume":"27","author":"Curley","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.canlet.2016.01.012_bib0470","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.canlet.2016.01.012_bib0475","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ejcts.2009.03.063","article-title":"The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer","volume":"36","author":"Tirino","year":"2009","journal-title":"Eur. J. Cardiothorac Surg"},{"key":"10.1016\/j.canlet.2016.01.012_bib0480","article-title":"Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0485","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0905653106","article-title":"Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment","volume":"106","author":"Bertolini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.01.012_bib0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086459","article-title":"Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor","volume":"9","author":"Murakami","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0495","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1038\/cddis.2012.211","article-title":"Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK\/ATM activation and diminished cell cycle arrest","volume":"4","author":"Lundholm","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.canlet.2016.01.012_bib0500","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1158\/0008-5472.CAN-13-1541","article-title":"CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist","volume":"74","author":"Sarvi","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0505","first-page":"2644","article-title":"Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review","volume":"6","author":"Qu","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0510","doi-asserted-by":"crossref","first-page":"9769","DOI":"10.1007\/s13277-014-2270-9","article-title":"The prognostic value of CD133 expression in non-small cell lung cancer: a meta-analysis","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0515","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2490-7-6","article-title":"Molecular and cellular characterization of ABCG2 in the prostate","volume":"7","author":"Pascal","year":"2007","journal-title":"BMC Urol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0520","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3390\/cancers3022106","article-title":"Cancer stem cells and side population cells in breast cancer and metastasis","volume":"3","author":"Britton","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2016.01.012_bib0525","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo","volume":"183","author":"Goodell","year":"1996","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2016.01.012_bib0530","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.lungcan.2010.04.020","article-title":"Characterization of side population cells in human malignant mesothelioma cell lines","volume":"70","author":"Kai","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0535","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-61779-854-2_13","article-title":"Detection of putative cancer stem cells of the side population phenotype in human tumor cell cultures","volume":"878","author":"Christgen","year":"2012","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0540","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.febslet.2004.03.123","article-title":"ABCG2\u2014a transporter for all seasons","volume":"567","author":"Sarkadi","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.canlet.2016.01.012_bib0545","article-title":"Inhibition of CK2alpha down-regulates Hedgehog\/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047919","article-title":"Cigarette smoke promotes drug resistance and expansion of cancer stem cell-like side population","volume":"7","author":"An","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0555","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2012.07.005","article-title":"Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy","volume":"78","author":"Fischer","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0560","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10059-013-0191-x","article-title":"Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype","volume":"36","author":"Yang","year":"2013","journal-title":"Mol. Cells"},{"key":"10.1016\/j.canlet.2016.01.012_bib0565","first-page":"1381","article-title":"Expression of CD44 in human lung tumors","volume":"54","author":"Penno","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0570","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jnci\/djj495","article-title":"The response of CD24(-\/low)\/CD44+ breast cancer-initiating cells to radiation","volume":"98","author":"Phillips","year":"2006","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2016.01.012_bib0575","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.bjc.6604242","article-title":"CD44+ CD24(-) prostate cells are early cancer progenitor\/stem cells that provide a model for patients with poor prognosis","volume":"98","author":"Hurt","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0580","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0585","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ejca.2010.02.024","article-title":"CD44, a therapeutic target for metastasising tumours","volume":"46","author":"Orian-Rousseau","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014062","article-title":"Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties","volume":"5","author":"Leung","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0595","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-4598-12-94","article-title":"Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes","volume":"12","author":"Gomez-Casal","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0600","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-2407-11-340","article-title":"Prognostic significance of CD44s expression in resected non-small cell lung cancer","volume":"11","author":"Ko","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2016.01.012_bib0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000243","article-title":"Identification of uPAR-positive chemoresistant cells in small cell lung cancer","volume":"2","author":"Gutova","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0610","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0463.2012.02955.x","article-title":"The liberated domain I of urokinase plasminogen activator receptor\u2014a new tumour marker in small cell lung cancer","volume":"121","author":"Almasi","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.canlet.2016.01.012_bib0615","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1158\/1535-7163.MCT-05-0082","article-title":"Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells","volume":"4","author":"Rao","year":"2005","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.canlet.2016.01.012_bib0620","doi-asserted-by":"crossref","first-page":"17758","DOI":"10.1074\/jbc.M601812200","article-title":"Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels","volume":"281","author":"Alfano","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.01.012_bib0625","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cas.12045","article-title":"Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy","volume":"104","author":"Kubo","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canlet.2016.01.012_bib0630","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2012.04.004","article-title":"Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446","volume":"323","author":"Qiu","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2016.01.012_bib0635","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","article-title":"KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation","volume":"13","author":"Miettinen","year":"2005","journal-title":"Appl. Immunohistochem. Mol. Morphol"},{"issue":"Suppl. 1","key":"10.1016\/j.canlet.2016.01.012_bib0640","first-page":"28","article-title":"Treatment of inoperable gastrointestinal stromal tumor (GIST) with Imatinib (Glivec, Gleevec)","volume":"97","author":"Joensuu","year":"2002","journal-title":"Med. Klin. (Munich)"},{"key":"10.1016\/j.canlet.2016.01.012_bib0645","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10549-014-3214-1","article-title":"C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast","volume":"149","author":"Liu","year":"2015","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.canlet.2016.01.012_bib0650","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10428199309145756","article-title":"Overexpression of c-kit in a leukemic cell population carrying a trisomy 4 and its relationship with the proliferative capacity","volume":"9","author":"Ferrari","year":"1993","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2016.01.012_bib0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052885","article-title":"KIT (CD117) expression in a subset of non-small cell lung carcinoma (NSCLC) patients","volume":"7","author":"Donnenberg","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.01.012_bib0660","doi-asserted-by":"crossref","first-page":"10486","DOI":"10.18632\/oncotarget.2395","article-title":"Nicotinic acetylcholine receptors induce c-Kit ligand\/Stem Cell Factor and promote stemness in an ARRB1\/ beta-arrestin-1 dependent manner in NSCLC","volume":"5","author":"Perumal","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2016.01.012_bib0665","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biopha.2013.04.005","article-title":"The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance","volume":"67","author":"Januchowski","year":"2013","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.canlet.2016.01.012_bib0670","first-page":"286","article-title":"Preliminary report on clinical trials of antabuse","volume":"60","author":"Bell","year":"1949","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.canlet.2016.01.012_bib0675","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0680","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ejpb.2014.08.002","article-title":"Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer","volume":"88","author":"Boyd","year":"2014","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"10.1016\/j.canlet.2016.01.012_bib0685","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrurol.2014.303","article-title":"Prostate cancer: copper unlocks therapeutic potential of disulfiram","volume":"11","author":"Thoma","year":"2014","journal-title":"Nat. Rev. Urol"},{"key":"10.1016\/j.canlet.2016.01.012_bib0690","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CMR.0b013e328334131d","article-title":"Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma","volume":"20","author":"Morrison","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1016\/j.canlet.2016.01.012_bib0695","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bbrc.2014.03.047","article-title":"Inhibitory effect of Disulfiram\/copper complex on non-small cell lung cancer cells","volume":"446","author":"Duan","year":"2014","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2016.01.012_bib0700","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.1424171112","article-title":"Suppression of cancer relapse and metastasis by inhibiting cancer stemness","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T21:58:13Z","timestamp":1654120693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383516000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0304383516000240"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.01.012","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung cancer stem cells: The root of resistance","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}